Aptevo Therapeutics Inc.APVONASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank30
3Y CAGR-42.2%
5Y CAGR-6.9%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-42.2%/yr
vs +58.7%/yr prior
5Y CAGR
-6.9%/yr
Recent deceleration
Acceleration
-100.9pp
Decelerating
Percentile
P30
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$8.71M-48.5%
2023$16.90M-25.3%
2022$22.64M-49.7%
2021$45.04M+12.7%
2020$39.98M+221.2%
2019$12.45M-59.4%
2018$30.64M+331.8%
2017$7.09M-26.7%
2016$9.68M+108.7%
2015$4.64M-